Study details
Enrolling now
SmartSteps Trial
Brigham and Women's Hospital
NCT IDNCT05378399ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
40
Study length
about 3.3 years
Ages
18+
Sex
Male only
Locations
1 site in MA
What this study is about
This trial is testing a device to help people with substance use disorder take PrEP medication every day. Participants will use a digital pill system and an app called Beiwe. It lasts for 1197 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Descovy or Truvada
- 2.Use Beiwe
- 3.Use ID-Cap System
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health, Immune, Infectious